Hosted on MSN13m
GILD Obtains Positive CHMP Opinion for Liver Disease DrugGilead Sciences, Inc. GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European ...
EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback